Across TCGA pan-cancer cohorts, CCDC190 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CCDC190 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher CCDC190 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CCDC190 expression acts as an unfavorable survival marker.

SCLC and LUSC are the cancer types where CCDC190 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	II,III,IV	0.137	0.700	<.001	48	view →
LUSC	DFS	Median	All	0.139	0.712	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CCDC190 tumor-vs-normal RNA expression · all CCDC190 data types